Cargando…

Symptomatic Cryptococcal Meningitis with Negative Serum and Cerebrospinal Fluid Cryptococcal Antigen Tests

BACKGROUND: Cryptococcal meningitis is a leading cause of mortality in advanced HIV disease. A positive cerebrospinal fluid cryptococcal antigen (CrAg) test defines cryptococcal meningitis. Herein, we present a patient with serum and cerebrospinal fluid CrAg negative cryptococcal meningitis, despite...

Descripción completa

Detalles Bibliográficos
Autores principales: Nanfuka, Vivien, Mkhoi, Mkhoi L, Gakuru, Jane, Kwizera, Richard, Baluku, Joseph Baruch, Bongomin, Felix, Meya, David B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420644/
https://www.ncbi.nlm.nih.gov/pubmed/34512034
http://dx.doi.org/10.2147/HIV.S328084
_version_ 1783748925975429120
author Nanfuka, Vivien
Mkhoi, Mkhoi L
Gakuru, Jane
Kwizera, Richard
Baluku, Joseph Baruch
Bongomin, Felix
Meya, David B
author_facet Nanfuka, Vivien
Mkhoi, Mkhoi L
Gakuru, Jane
Kwizera, Richard
Baluku, Joseph Baruch
Bongomin, Felix
Meya, David B
author_sort Nanfuka, Vivien
collection PubMed
description BACKGROUND: Cryptococcal meningitis is a leading cause of mortality in advanced HIV disease. A positive cerebrospinal fluid cryptococcal antigen (CrAg) test defines cryptococcal meningitis. Herein, we present a patient with serum and cerebrospinal fluid CrAg negative cryptococcal meningitis, despite a positive cerebrospinal fluid India ink examination and quantitative culture. CASE DETAILS: A 56-year-old HIV-positive Ugandan woman, with an undetectable HIV RNA viral load and CD4+ T-cell count of 766 cells per microlitre presented with signs and symptoms consistent with cryptococcal meningitis. Her serum and cerebrospinal fluid CrAg tests were negative despite having a positive cerebrospinal fluid India ink and quantitative culture. On day 1, she was commenced on intravenous amphotericin B deoxycholate (1mg/kg) for 3 days (considering 10 CFU growth of Cryptococcus spp) in combination with oral flucytosine (100mg/kg) for 7 days and then fluconazole 1200mg once daily for the next 11 days. By day 7, she was symptom free and quantitative cerebrospinal fluid culture was negative for Cryptococcus spp. She was discharged on day 9. At 10 weeks (day +40) and 18 weeks (day +72), she was well and adherent to her antiretroviral therapy and on maintenance phase of cryptococcal meningitis on fluconazole at a dose of 400mg once daily. CONCLUSION: This report alerts clinicians managing patients with HIV-associated cryptococcal meningitis to four uncommon clinical scenarios; first, the possibility of negative serum and cerebrospinal fluid CrAg lateral flow assay results in the context of low cerebrospinal fluid fungal burden in a symptomatic patient. Second, possible occurrence of cryptococcal meningitis in a patient with high CD4 T-cell lymphocyte counts. Third, an early seroconversion of cryptococcal antigenaemia following effective fluconazole therapy. Fourth, an early symptomatic relapse of cryptococcal meningitis albeit negative serum CrAg.
format Online
Article
Text
id pubmed-8420644
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84206442021-09-09 Symptomatic Cryptococcal Meningitis with Negative Serum and Cerebrospinal Fluid Cryptococcal Antigen Tests Nanfuka, Vivien Mkhoi, Mkhoi L Gakuru, Jane Kwizera, Richard Baluku, Joseph Baruch Bongomin, Felix Meya, David B HIV AIDS (Auckl) Case Report BACKGROUND: Cryptococcal meningitis is a leading cause of mortality in advanced HIV disease. A positive cerebrospinal fluid cryptococcal antigen (CrAg) test defines cryptococcal meningitis. Herein, we present a patient with serum and cerebrospinal fluid CrAg negative cryptococcal meningitis, despite a positive cerebrospinal fluid India ink examination and quantitative culture. CASE DETAILS: A 56-year-old HIV-positive Ugandan woman, with an undetectable HIV RNA viral load and CD4+ T-cell count of 766 cells per microlitre presented with signs and symptoms consistent with cryptococcal meningitis. Her serum and cerebrospinal fluid CrAg tests were negative despite having a positive cerebrospinal fluid India ink and quantitative culture. On day 1, she was commenced on intravenous amphotericin B deoxycholate (1mg/kg) for 3 days (considering 10 CFU growth of Cryptococcus spp) in combination with oral flucytosine (100mg/kg) for 7 days and then fluconazole 1200mg once daily for the next 11 days. By day 7, she was symptom free and quantitative cerebrospinal fluid culture was negative for Cryptococcus spp. She was discharged on day 9. At 10 weeks (day +40) and 18 weeks (day +72), she was well and adherent to her antiretroviral therapy and on maintenance phase of cryptococcal meningitis on fluconazole at a dose of 400mg once daily. CONCLUSION: This report alerts clinicians managing patients with HIV-associated cryptococcal meningitis to four uncommon clinical scenarios; first, the possibility of negative serum and cerebrospinal fluid CrAg lateral flow assay results in the context of low cerebrospinal fluid fungal burden in a symptomatic patient. Second, possible occurrence of cryptococcal meningitis in a patient with high CD4 T-cell lymphocyte counts. Third, an early seroconversion of cryptococcal antigenaemia following effective fluconazole therapy. Fourth, an early symptomatic relapse of cryptococcal meningitis albeit negative serum CrAg. Dove 2021-09-01 /pmc/articles/PMC8420644/ /pubmed/34512034 http://dx.doi.org/10.2147/HIV.S328084 Text en © 2021 Nanfuka et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Case Report
Nanfuka, Vivien
Mkhoi, Mkhoi L
Gakuru, Jane
Kwizera, Richard
Baluku, Joseph Baruch
Bongomin, Felix
Meya, David B
Symptomatic Cryptococcal Meningitis with Negative Serum and Cerebrospinal Fluid Cryptococcal Antigen Tests
title Symptomatic Cryptococcal Meningitis with Negative Serum and Cerebrospinal Fluid Cryptococcal Antigen Tests
title_full Symptomatic Cryptococcal Meningitis with Negative Serum and Cerebrospinal Fluid Cryptococcal Antigen Tests
title_fullStr Symptomatic Cryptococcal Meningitis with Negative Serum and Cerebrospinal Fluid Cryptococcal Antigen Tests
title_full_unstemmed Symptomatic Cryptococcal Meningitis with Negative Serum and Cerebrospinal Fluid Cryptococcal Antigen Tests
title_short Symptomatic Cryptococcal Meningitis with Negative Serum and Cerebrospinal Fluid Cryptococcal Antigen Tests
title_sort symptomatic cryptococcal meningitis with negative serum and cerebrospinal fluid cryptococcal antigen tests
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420644/
https://www.ncbi.nlm.nih.gov/pubmed/34512034
http://dx.doi.org/10.2147/HIV.S328084
work_keys_str_mv AT nanfukavivien symptomaticcryptococcalmeningitiswithnegativeserumandcerebrospinalfluidcryptococcalantigentests
AT mkhoimkhoil symptomaticcryptococcalmeningitiswithnegativeserumandcerebrospinalfluidcryptococcalantigentests
AT gakurujane symptomaticcryptococcalmeningitiswithnegativeserumandcerebrospinalfluidcryptococcalantigentests
AT kwizerarichard symptomaticcryptococcalmeningitiswithnegativeserumandcerebrospinalfluidcryptococcalantigentests
AT balukujosephbaruch symptomaticcryptococcalmeningitiswithnegativeserumandcerebrospinalfluidcryptococcalantigentests
AT bongominfelix symptomaticcryptococcalmeningitiswithnegativeserumandcerebrospinalfluidcryptococcalantigentests
AT meyadavidb symptomaticcryptococcalmeningitiswithnegativeserumandcerebrospinalfluidcryptococcalantigentests